Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Jacques Col"'
Autor:
Sarah Figarol, Célia Delahaye, Rémi Gence, Aurélia Doussine, Juan Pablo Cerapio, Mathylda Brachais, Claudine Tardy, Nicolas Béry, Raghda Asslan, Jacques Colinge, Jean-Philippe Villemin, Antonio Maraver, Irene Ferrer, Luis Paz-Ares, Linda Kessler, Francis Burrows, Isabelle Lajoie-Mazenc, Vincent Dongay, Clara Morin, Amélie Florent, Sandra Pagano, Estelle Taranchon-Clermont, Anne Casanova, Anne Pradines, Julien Mazieres, Gilles Favre, Olivier Calvayrac
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Drug-tolerance has emerged as one of the major non-genetic adaptive processes driving resistance to targeted therapy (TT) in non-small cell lung cancer (NSCLC). However, the kinetics and sequence of molecular events governing this adaptive r
Externí odkaz:
https://doaj.org/article/5612bcd3b3224ee3a0571c7b20e6c3df
Autor:
Léa Marty, Alain Hoornaert, Bénédicte Enkel, Alan Penhoat, Jacques Colat-Parros, Assem Soueidan, Fabienne Jordana
Publikováno v:
Dentistry Journal, Vol 12, Iss 8, p 240 (2024)
Background: The aim of this meta-analysis was to evaluate the role of a history of periodontitis on implant failure. The two main judgment criteria studied are peri-implantitis and the survival rate. The two secondary judgment criteria studied are th
Externí odkaz:
https://doaj.org/article/b99974bc8d72449bb9a80d2761e479d8
Autor:
Lena M. Sauer, Rodrigo Canovas, Daniel Roche, Hosam Shams-Eldin, Patrice Ravel, Jacques Colinge, Ralph T. Schwarz, Choukri Ben Mamoun, Eric Rivals, Emmanuel Cornillot
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-19 (2023)
Abstract Background Protozoan parasites are known to attach specific and diverse group of proteins to their plasma membrane via a GPI anchor. In malaria parasites, GPI-anchored proteins (GPI-APs) have been shown to play an important role in host–pa
Externí odkaz:
https://doaj.org/article/bbb75fbdd038457eb6a28f2abb56c317
Autor:
Evelyne Lopez-Crapez, Luca Costa, Guillaume Tosato, Jeanne Ramos, Thibault Mazard, Janique Guiramand, Alain Thierry, Jacques Colinge, Pierre-Emmanuel Milhiet, Christine Bénistant
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Besides the standard parameters used for colorectal cancer (CRC) management, new features are needed in clinical practice to improve progression-free and overall survival. In some cancers, the microenvironment mechanical properties can contr
Externí odkaz:
https://doaj.org/article/b8dea8acb05240069e9e7ddb5155b135
Autor:
Richard C. Becker, Harvey D. White, Shaun G. Goodman, Elliott M. Antman, John Ducas, Richard L. Gallo, James J. Ferguson, Glenn N. Levine, Kenneth W. Mahaffey, Jacques Col, Robert M. Califf, Anatoly Langer, Sarah A. Spinler, Philip E. Aylward, Simon T. Tonev
Publikováno v:
International Journal of Cardiology. 139:123-133
Background: Obese patients are at increased risk of acute coronary syndromes (ACS). We evaluated the prevalence of obesity in a large ACS population, as well as the relationship between body mass index (BMI) and the use of cardiac medications and pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf5b3d226d36ec0563ca87c9ed51817
https://doi.org/10.1016/j.ijcard.2008.10.008
https://doi.org/10.1016/j.ijcard.2008.10.008
Autor:
Judith S. Hochman, John K. French, Vladimir Dzavik, S. Chiu Wong, Jacques Col, Shannon M. Harkness, Lynn A. Sleeper, Harvey D. White
Publikováno v:
The American Journal of Cardiology. 104:24-28
Myocardial infarction often develops when thrombosis occurs at lesions that have not previously been flow limiting. However, the development of cardiogenic shock complicating acute myocardial infarction in such circumstances has received little atten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd3ccb829ae8c423b3e7e6e7fa295c9e
https://doi.org/10.1016/j.amjcard.2009.03.002
https://doi.org/10.1016/j.amjcard.2009.03.002
Autor:
Emilia Rabia, Véronique Garambois, Christine Dhommée, Christel Larbouret, Laurie Lajoie, Yoan Buscail, Gabriel Jimenez-Dominguez, Sylvie Choblet-Thery, Emmanuelle Liaudet-Coopman, Martine Cerutti, Marta Jarlier, Patrice Ravel, Laurent Gros, Nelly Pirot, Gilles Thibault, Eugene A. Zhukovsky, Pierre-Emmanuel Gérard, André Pèlegrin, Jacques Colinge, Thierry Chardès
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The ErbB family of receptor tyrosine kinases is a primary target for small molecules and antibodies for pancreatic cancer treatment. Nonetheless, the current treatments for this tumor are not optimal due to lack of efficacy, resistance, or toxicity.
Externí odkaz:
https://doaj.org/article/8a10b603d78a414f85898e71f788257b
Autor:
Shaun G. Goodman, James W. Hoekstra, Charles V. Pollack, Robert M. Califf, Jacques Col, Kenneth W. Mahaffey, James J. Ferguson, Marc Cohen, Elliott M. Antman, Anatoly Langer, Harvey D. White, Karen S. Pieper
Publikováno v:
Journal of the American College of Cardiology. 48:1346-1354
OBJECTIVES The purpose of this study was to compare the effect of receiving pretreatment with antithrombin before randomization as well as overall efficacy and safety of enoxaparin versus unfractionated heparin (UFH) in the SYNERGY (Superior Yield of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e10a372295fc5fe2b3443ee493d96179
https://doi.org/10.1016/j.jacc.2006.05.058
https://doi.org/10.1016/j.jacc.2006.05.058
Autor:
SHAMIR R. MEHTA, M. D, M. SC, CHRISTOPHER B. GRANGER, WILLIAM E. BODEN, PHILIPPE GABRIEL STEG, JEAN PIERRE BASSAND, DAVID P. FAXON, RIZWAN AFZAL, SUSAN CHROLAVICIUS, R. N, SANJIT S. JOLLY, PETR WIDIMSKY, ALVARO AVEZUM, HANS JURGEN RUPPRECHT, JUN ZHU, JACQUES COL, MADHU K. NATARAJAN, CRAIG HORSMAN, B. SC, KEITH A. A. FOX, M. B, C.H. B, AND SALIM YUSUF, M. B, B. S, D. PHIL, PIZZOLATO, GILBERTO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01099::7ccf32a8560aad1ef99f00d950e4fdb3
https://hdl.handle.net/11368/2288197
https://hdl.handle.net/11368/2288197
Publikováno v:
European Heart Journal Supplements. 3:J24-J31
Options for antiplatelet therapy have increased in the last decade, with thienopyridines and GP IIb/IIIa receptor antagonists joining aspirin on the roster of available antiplatelet agents. Both North American (ACC/AHA) and European (ESC) cardiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d1feff4a2af9e23327934ae67177f24
https://doi.org/10.1016/s1520-765x(01)90137-3
https://doi.org/10.1016/s1520-765x(01)90137-3